Well-acknowledged conventional clinicopathological prognostic factors like histological tumor grade, lymph node metastases, human epidermal growth factor receptor 2/neu protooncogene (HER2-neu), progesterone receptor (PR), and estrogen receptor (ER) status are routinely considered in all probable cases of carcinoma of the breast. This evidence concerns the gene PGR and breast carcinoma.